Pocket Program - CROI

Monday
March 4 Oral Sessions
Session 17 CROI 2013
e Monday, 4-6 pm; B406
Session 17–Symposium
Is Something Bugging You?
Conveners:
Giulia Marchetti, San Paolo Hosp,
Univ of Milan, Italy
John Zaunders, St Vincent’s Hosp,
Sydney, Australia
51
The Human Microbiome in Health and
Immunodeficient States
Frederic Bushman*, G Wu, J Lewis, H Li, K Bittinger,
E Charlson, C Hoffmann, and R Collman
Univ of Pennsylvania Perleman Sch of Med, Philadelphia, US
52
HIV and SIV Pathogenesis at the Interface of
Gut Mucosal Immune Defense and Microbiota
I Grishina, L Hirao, L Nagy, S Sankaran, A Baumler, M Marco,
H Cheng, and Satya Dandekar*
Univ of California, Davis, US
53
Treating Microbial Translocation in
Progressive HIV/SIV Infections
N Klatt 1 , Z Klase 1 , M Quinones 2 , D Hazuda 3 , M Miller 4 , J Segre 5 ,
J Lifson 6 , E Haddad 7 , J Estes 6 , and Jason Brenchley* 1
1 Prgm in Barrier Immunity and Repair, NIAID, NIH, Bethesda,
MD, US;; 2 Bioinformatics and Computational Biosci Branch
OCICB, OSMO, OD, NIAID, NIH, Bethesda, MD, US;; 3 Merck
Res Labs, West Point, PA, US;; 4 Gilead Sci, Inc., Foster City, CA,
US;; 5 Genetics and Molecular Microbio Branch, NHGRI, NIH,
Bethesda, MD, US;; 6 ACVP, SAIC-Frederick, Inc, Frederick Natl
Lab for Cancer Res, MD, US;; and 7 Vaccine and Gene Therapy
Inst-Florida, Port St Lucie, US
54
The Enteric Virome in AIDS
S Handley 1 , L Thackray 1 , G Zhao 1 , R Presti 1 , J Brenchley 2 ,
R Veazey 3 , T Stappenbeck 1 , D Wang 1 , D Barouch 4,5 ,
and Herbert Virgin* 1
1 Washington Univ Sch of Med, St Louis, MO, US;; 2 Lab of
Molecular Microbio, NIAID, NIH, Bethesda, MD, US;; 3 Tulane
Natl Primate Res Ctr, Tulane Univ Sch of Med, Covington, LA,
US;; 4 Ctr for Virology and Vaccine Res, Beth Israel Deaconess
Med Ctr, Boston, MA, US;; and 5 Ragon Inst of MGH, MIT, and
Harvard Med Sch, Boston, MA, US
5:30-6 pm
Panel Discussion
Objectives: This session is directed to clinicians and scientists
interested in understanding the roles of the microbiome and the
virome in the pathogenesis of HIV infection and AIDS. Recent
discoveries in these areas will be discussed. It is assumed that
participants are familiar with the general concept of microbiomes
and have some understanding of the molecular mechanisms used
for its investigation. At the completion of the session, participants
will be knowledgeable about the gut and lung microbiomes, the
alterations in the gut virome associated with lentiviral infections,
and their influence in pathogenesis.
8 20th Conference on Retroviruses and Opportunistic Infections
e Monday, 4-6 pm; Ballroom 3-4
Session 18–Symposium
Preventing HIV/AIDS in the US: Can We Do Better?
Conveners:
Wayne Duffus, CDC, Atlanta, GA, US
Monica Sweeney, New York City Dept
of Hlth, NY, US
55
Drivers of the HIV Epidemic in the Southern
US
Adaora Adimora
Univ of North Carolina at Chapel Hill, US
56
What Do Sexual Networks Tell Us about How
to Block Transmission?
Steven Goodreau
Univ of Washington, Seattle, US
57
How Should We Spend Our Prevention
Dollars?
Carlos del Rio
Emory Univ Ctr for AIDS Res, Atlanta, GA, US
58
Addressing the Cascade of Care
Alan Greenberg
George Washington Univ and District of Columbia Devt Ctr for
AIDS Res, US
5:30-6 pm
Panel Discussion
Objectives: This session is directed to clinicians and scientists
interested in HIV prevention, treatment, and policy. It is assumed
participants are familiar with basic knowledge of HIV epidemiology
in the US, and HIV prevention and treatment modalities. At the
completion of the session, participants will be knowledgeable about
which populations in the US are not being reached adequately,
factors that may be driving these failures to prevent HIV infection
and diagnose and adequately treat HIV infected persons, and some
proposed solutions for addressing the HIV/AIDS epidemic in the US.